Murat Akand

14PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Occupational epidemiologySolid tumoursNephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 15, 2026
Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.

|Dec 23, 2025
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?

Jonas Mennes, Murat Akand, Rodrigue Benijts

|Nov 09, 2024
Cohort Profile: VZNKUL-NMIBC Quality Indicators Program: A Flemish Prospective Cohort to Evaluate the Quality Indicators in the Treatment of Non-Muscle-Invasive Bladder Cancer.

Murat Akand, Ralf Veys, Dieter Ost

|Jun 29, 2021
Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non-muscle-invasive bladder cancer.

Tim Muilwijk, Murat Akand, Frank Van der Aa

|Nov 25, 2020
A survey analysis of knowledge levels of urologists about radiation safety and fluoroscopy use.

Emre Altintas, Tuncer Bahceci, Ali Furkan Batur

|Jul 09, 2020
The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.

Tim Muilwijk, Murat Akand, Francesco Soria

Pageof 3

Frequent Collaborators

4 joint publications

Steven Joniau

3 joint publications

Özcan Kılıç

2 joint publications

İsmail Harmankaya

2 joint publications

Maarten Albersen